The Effect of Polycystic Ovary Syndrome Treatment on Metabolomics
Launched by INONU UNIVERSITY · Apr 1, 2021
Trial Information
Current as of June 20, 2025
Unknown status
Keywords
ClinConnect Summary
Polycystic ovary syndrome (PCOS), is the most common endocrinological disorder that affects the reproductive aged women. In addition to causing problems such as menstrual irregularity, hirsutism, acne, it is also an important health problem that can cause infertility, insulin resistance, impaired glucose metabolism, diabetes, high blood pressure, heart disease, dyslipidemia in advanced ages. Diagnostic criteria also vary widely in these patients. These patients are often overweight or obese, and abdominal adiposity is common in these patients. The patients also suffer from insulin resistanc...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients who are diagnosed with polycystic ovary syndrome according to Rotterdam criteria and who do not have any additional chronic systemic disease
- Exclusion Criteria:
- • The presence of any diseases that cause hormonal disorders and any chronic systemic diseases, the patients who are already under any treatment for polycystic ovary syndrome
About Inonu University
Inonu University is a prominent academic institution located in Turkey, dedicated to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative research initiatives aimed at improving patient care and advancing scientific knowledge. With a strong commitment to ethical standards and regulatory compliance, Inonu University collaborates with various stakeholders, including healthcare professionals and industry partners, to conduct rigorous clinical trials that contribute to the development of new therapies and treatment modalities. Through its research endeavors, the university strives to enhance healthcare outcomes and foster a culture of inquiry within the medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Malatya, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials